Skip Navigation
Department of Health and Human Services www.hhs.gov
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Presentation to Slide Tray Presentation:

Disease-Modifying Antirheumatic Drugs in Children With Juvenile Idiopathic Arthritis

Slide: 27 of 46

Summary: Nonbiologic and Biologic DMARDs Compared With Conventional Anti-inflammatoryTreatments (1 of 2)

Improved ESR is inconsistently associated with treatment, and the evidence is insufficient to estimate treatment effects. ESR is influenced by many factors that may be unrelated to treatment.

The evidence about how both biologic and nonbiologic DMARDs affect radiographic evidence of disease progression is insufficient to permit a conclusion about treatment effects.